Elsevier Inc.

SHERPA: Unknown

People

  1. Giralt
    Giralt
  2. Perales
    Perales
  3. Jakubowski
    Jakubowski
  4. Shah
    Shah
  5. Papadopoulos
    Papadopoulos
  6. Scordo
    Scordo
  7. Devlin
    Devlin
  8. Landau
    Landau
  9. Ponce
    Ponce
  10. Castro-Malaspina
    Castro-Malaspina

Groups

  1. Hematologic Malignancies, Division of (1609)
  2. Department of Medicine (1594)
  3. Center for Hematologic Malignancies (1283)
  4. Bone Marrow Transplant (734)
  5. Survivorship Research (509)
  6. GSK Faculty (414)
  7. CTCR Scholars (318)
  8. Sloan Kettering Institute Faculty (307)
  9. Epidemiology and Biostatistics (303)
  10. Biostatistics Service (291)
Search Within
  1. "Hematologic Malignancies, Division of"
Formats
  1. Meeting Abstract (829)
  2. Journal Article (637)
  3. Review (67)
  4. Guidelines (24)
  5. Editorial (19)
  6. Book Section (14)
  7. Conference Paper (11)
  8. Correspondence (4)
  9. Research Letter (3)
  10. Miscellaneous (1)
Groups
  1. Hematologic Malignancies, Division of (1609)
  2. Department of Medicine (1594)
  3. Center for Hematologic Malignancies (1283)
  4. Bone Marrow Transplant (734)
  5. Survivorship Research (509)
  6. GSK Faculty (414)

More Groups

People
  1. Sergio Giralt (384)
  2. Miguel-Angel Perales (300)
  3. Sean Devlin (172)
  4. Ann Jakubowski (164)
  5. Juliet Barker (157)
  6. Marcel Van Den Brink (150)

More People

Years
  1. 2025 (25)
  2. 2024 (96)
  3. 2023 (129)
  4. 2022 (144)
  5. 2021 (104)
  6. 2020 (159)

More Years

Publications
  1. Biology of Blood and Marrow Transplantation (596)
  2. Clinical Lymphoma, Myeloma and Leukemia (328)
  3. Transplantation and Cellular Therapy (127)
  4. Gynecologic Oncology (95)
  5. International Journal of Radiation Oncology, Biology, Physics (66)
  6. Journal of Thoracic Oncology (55)

More Publications

Results (1609)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The impact of the time of day of radiotherapy and systemic therapy on disease control in locally advanced non -small cell lung cancer treated with chemoradiation and durvalumab
    Meeting Abstract

    McMillan, M. T.; Shepherd, A. F.; Cooper, A. J.; Schoenfeld, A. J.; Wu, A. J.; Simone, C. B. 2nd; Iyengar, P.; Gelblum, D.; Chaft, J.; Gomez, D. R.; more...
    International Journal of Radiation Oncology, Biology, Physics (2024)

    Fulltext@MSK | Save
  • Factors associated with an inconclusive result from commercial homologous recombination deficiency testing in ovarian cancer
    Meeting Abstract

    Sullivan, M.; Graves, S.; Adkoli, A.; Zhou, Q.; Iasonos, A.; Ellenson, L.; Chi, D.; O'Cearbhaill, R.; Weigelt, B.; Grisham, R.
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • Examining health-related quality of life outcomes among older patients with advanced ovarian cancer treated with niraparib first-line maintenance therapy in context with efficacy and safety findings: Results from the PRIMA/ENGOT-OV26/GOG-3012 trial
    Meeting Abstract

    Pothuri, B.; Valabrega, G.; Oaknin, A.; Graybill, W.; Sánchez, A. B.; McCormick, C.; Baurain, J. F.; Tinker, A.; Denys, H.; O'Cearbhaill, R.; more...
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • A phase I/II study of ubamatamab (REGN4018), a MUC16xCD3 bispecific antibody, administered alone or in combination with cemiplimab (anti-PD-1) in patients with recurrent ovarian cancer or MUC16+endometrial cancer: Trial in progress update
    Meeting Abstract

    Liu, J.; O'Malley, D.; Van Nieuwenhuysen, E.; O'Cearbhaill, R.; Bouberhan, S.; Moore, K.; Hou, J.; Hamilton, E.; Yoo, S. Y.; Wang, B.; more...
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • Prognostic value of aggressive histology in surgically-staged, clinically uterine-confined endometrial carcinoma
    Meeting Abstract

    Dagher, C.; Mueller, J.; Abu-Rustum, N.; Sonoda, Y.; Momeni-Boroujeni, A.; Makker, V.; O'Cearbhaill, R.; Alektiar, K.; Leitao, M.
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • Molecular and tumor microenvironmental characterization of HPV-negative invasive squamous cell carcinoma of the vulva
    Meeting Abstract

    Moufarrij, S.; Filippova, O.; Paula, A. D.; Heredia, J. B.; Leitao, M.; O'Cearbhaill, R.; Abu-Rustum, N.; Park, K.; Weigelt, B.; Zamarin, D.
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • Folate receptor positivity in low-grade serous ovarian cancer: Exploring new therapeutic possibilities
    Meeting Abstract

    Manning-Geist, B.; Sullivan, M.; Zhou, Q.; Iasonos, A.; Stallworth, C.; Liu, Y.; Roche, K. L.; Gordhandas, S.; Chi, D.; O'Cearbhaill, R.; more...
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • Progression-free and overall survival in newly-diagnosed homologous recombination DNA-repair deficient ovarian cancer without a BRCA mutation
    Meeting Abstract

    Graves, S.; Sullivan, M.; Adkoli, A.; Zhou, Q.; Chi, D.; Ellenson, L.; O'Cearbhaill, R.; Weigelt, B.; Grisham, R.
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • Overall survival and progression-free survival by PD-L1 status among endometrial cancer patients treated with pembrolizumab plus carboplatin/paclitaxel as compared to carboplatin/paclitaxel plus placebo in the NRG GY018 trial
    Meeting Abstract

    Eskander, R.; Sill, M.; Beffa, L.; Moore, R.; Hope, J.; Musa, F.; Mannel, R.; Shahin, M.; Cantuaria, G.; Girda, E.; more...
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • Idecabtagene vicleucel (ide-cel) versus standard regimens (SRs) in triple-class-exposed (TCE) relapsed and refractory multiple myeloma (RRMM): KarMMa-3 sub-analysis of black patients
    Meeting Abstract

    Patel, K. K.; Rodríguez-Otero, P.; Nooka, A. K.; Callander, N. S.; Solomon, S. R.; Baz, R.; Sborov, D. W.; Gergis, U.; Badros, A. Z.; Giralt, S. A.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2024)

    Fulltext@MSK | Save